NO174877C - Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning - Google Patents

Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning

Info

Publication number
NO174877C
NO174877C NO873243A NO873243A NO174877C NO 174877 C NO174877 C NO 174877C NO 873243 A NO873243 A NO 873243A NO 873243 A NO873243 A NO 873243A NO 174877 C NO174877 C NO 174877C
Authority
NO
Norway
Prior art keywords
pct
drug
preparation
antitumor effect
sec
Prior art date
Application number
NO873243A
Other languages
English (en)
Norwegian (no)
Other versions
NO873243D0 (no
NO873243L (no
NO174877B (no
Inventor
Hansjoerg Eibl
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of NO873243D0 publication Critical patent/NO873243D0/no
Publication of NO873243L publication Critical patent/NO873243L/no
Publication of NO174877B publication Critical patent/NO174877B/no
Publication of NO174877C publication Critical patent/NO174877C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/24—Esteramides
    • C07F9/2454—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458—Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Steroid Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Electrically Operated Instructional Devices (AREA)
NO873243A 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning NO174877C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3542893 1985-12-04
DE3606631 1986-02-28
PCT/EP1986/000705 WO1987003480A2 (en) 1985-12-04 1986-12-04 Medicament with anti-tumoral action containing hexadecylphosphocholine

Publications (4)

Publication Number Publication Date
NO873243D0 NO873243D0 (no) 1987-08-03
NO873243L NO873243L (no) 1987-10-02
NO174877B NO174877B (no) 1994-04-18
NO174877C true NO174877C (no) 1994-07-27

Family

ID=25838509

Family Applications (2)

Application Number Title Priority Date Filing Date
NO873243A NO174877C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning
NO873244A NO175620C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO873244A NO175620C (no) 1985-12-04 1987-08-03 Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel

Country Status (15)

Country Link
US (2) US4837023A (instruction)
EP (4) EP0248062B1 (instruction)
JP (2) JPH0637393B2 (instruction)
AT (2) ATE75608T1 (instruction)
CA (2) CA1338627C (instruction)
DE (4) DE3641379A1 (instruction)
DK (2) DK172954B1 (instruction)
ES (2) ES2038215T3 (instruction)
FI (2) FI873363A0 (instruction)
GR (2) GR3002487T3 (instruction)
HU (2) HU203201B (instruction)
IE (2) IE59778B1 (instruction)
NO (2) NO174877C (instruction)
PT (2) PT83872B (instruction)
WO (2) WO1987003480A2 (instruction)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916884A (en) * 1985-12-04 1999-06-29 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Compositions containing a mixture of phosphorus compounds and alkylglycerols
CA2001401A1 (en) * 1988-10-25 1990-04-25 Claude Piantadosi Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
ES2086395T3 (es) * 1989-08-10 1996-07-01 Sandoz Ltd Fosfolipidos para el tratamiento de esclerosis multiple.
US5182271A (en) * 1989-08-10 1993-01-26 Sandoz Ltd. Thioether, keto-ester and alkyl phospholipids useful in treating multiple sclerosis
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate
US5506217A (en) * 1991-04-25 1996-04-09 The University Of British Columbia Phosphonates as anti-cancer agents
US5369097A (en) * 1991-04-25 1994-11-29 The University Of British Columbia Phosphonates as anti-cancer agents
DE59208905D1 (de) * 1991-07-04 1997-10-23 Asta Medica Ag Verfahren zur Herstellung von Alkylphosphocholinen und Reinherstellung derselben
US6254879B1 (en) 1991-09-27 2001-07-03 Max-Planck-Gessellschaft zun Förderung der Wissenschaften e.V. Methods of treating protozoal diseases
DE4132344A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
US5298655A (en) * 1991-09-27 1994-03-29 Merck & Co., Inc. Farnesyl pyrophosphate analogs
DE4222910A1 (de) * 1992-07-11 1994-01-13 Asta Medica Ag Neue Phospholipidderivate
US6172050B1 (en) 1992-07-11 2001-01-09 Asta Medica Aktiengesellschaft Phospholipid derivatives
DE4235911A1 (de) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern
ATE226437T1 (de) * 1993-06-10 2002-11-15 Univ Wake Forest (phospho)lipide zum bekämpfen einer hepatitis b- infektion
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
ATE244570T1 (de) 1993-09-09 2003-07-15 Lorus Therapeutics Inc Immunmodulierende zusammensetzungen aus galle
AU3216695A (en) * 1994-08-29 1996-03-22 University Of North Carolina At Chapel Hill, The Lipid analogs for treating viral infections
US7135584B2 (en) * 1995-08-07 2006-11-14 Wake Forest University Lipid analogs for treating viral infections
US5574025A (en) * 1994-10-26 1996-11-12 Merck & Co., Inc. Inhibitors of prenyl-protein transferases
AU1573495A (en) * 1995-02-10 1996-08-27 University Of British Columbia, The {4-hexadecyl-3-methoxy-butyl} phosphonic acid and its protienconjugates useful as anti-cancer agents
EP0814821A1 (en) 1995-03-16 1998-01-07 Imutec Pharma Inc. Immunomodulating compositions from bile for the treatment of immune system disorders
KR100499190B1 (ko) * 1996-03-29 2006-04-17 교와 핫꼬 고교 가부시끼가이샤 육모제
US20040101569A1 (en) * 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
US6121245A (en) * 1997-01-29 2000-09-19 Firshein; Richard N. Method of treating cancer using alkylglycerols in conjunction with chemotherapy
SE9701912D0 (sv) * 1997-05-22 1997-05-22 Interhealth Ab Pharmaceutical composition and use thereof
US7582678B2 (en) * 1997-07-09 2009-09-01 D-Pharm Limited Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
PT1051159E (pt) * 1998-01-22 2002-09-30 Zentaris Ag Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose
US7026469B2 (en) * 2000-10-19 2006-04-11 Wake Forest University School Of Medicine Compositions and methods of double-targeting virus infections and cancer cells
IL137672A0 (en) 2000-08-03 2001-10-31 Dpharm Ltd Derivatives of branched-chain lipophilic molecules and uses thereof
US7309696B2 (en) 2000-10-19 2007-12-18 Wake Forest University Compositions and methods for targeting cancer cells
CN1486289A (zh) * 2001-05-29 2004-03-31 皇家菲利浦电子有限公司 金属-陶瓷的结合
WO2003021959A1 (en) * 2001-08-31 2003-03-13 Thomson Licensing Sa Sequence counter for an audio visual stream
AU2002346284A1 (en) * 2002-04-26 2003-11-10 Rudolf Perl Pharmaceutical compositions of phospholipid derivatives
US20050187191A1 (en) * 2004-02-20 2005-08-25 Kucera Louis S. Methods and compositions for the treatment of respiratory syncytial virus
KR101378005B1 (ko) 2005-12-19 2014-03-27 아에테르나 젠타리스 게엠베하 세포독성이 감소된 알킬 인지질 유도체 및 이의 용도
EP2120873B1 (en) * 2006-12-20 2012-06-27 Alphaptose Gmbh Topical dosage form comprising tri-substituted glycerol compounds
JP2011057647A (ja) * 2009-09-14 2011-03-24 Adeka Corp 化粧料
JP6441073B2 (ja) 2011-06-24 2018-12-19 ジーアールアイ バイオ, インコーポレイテッドGRI Bio, Inc. 炎症状態の予防および処置
CN102491994B (zh) * 2011-12-07 2014-10-15 宁波九胜创新医药科技有限公司 一种胆碱磷酸烷基酯的制备方法
AU2015360945B2 (en) * 2014-12-09 2021-07-29 Gri Bio, Inc. Prevention and treatment of inflammatory conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225227A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Derivate des n.n-bis-(2-chlor-aethyl)-phosphorsaeureamids
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
JPS60184092A (ja) 1984-03-01 1985-09-19 Kao Corp リン酸エステルおよびその製法

Also Published As

Publication number Publication date
NO873244L (no) 1987-10-01
GR3002487T3 (en) 1992-12-30
ATE64529T1 (de) 1991-07-15
EP0248062A1 (de) 1987-12-09
EP0248062B1 (de) 1992-05-06
PT83873B (pt) 1989-01-17
US4837023A (en) 1989-06-06
NO873243D0 (no) 1987-08-03
GR3005168T3 (instruction) 1993-05-24
WO1987003480A3 (en) 1988-02-25
DE3641379A1 (de) 1987-09-03
EP0225608A2 (de) 1987-06-16
DK398587D0 (da) 1987-07-30
HU203201B (en) 1991-06-28
US5049552A (en) 1991-09-17
PT83873A (de) 1987-01-01
IE59777B1 (en) 1994-04-06
DK172954B1 (da) 1999-10-18
NO873243L (no) 1987-10-02
ES2032755T3 (es) 1993-03-01
NO175620C (no) 1994-11-09
EP0230575A3 (de) 1987-12-02
JPH0637393B2 (ja) 1994-05-18
DK393187D0 (da) 1987-07-28
CA1280369C (en) 1991-02-19
JPS63501719A (ja) 1988-07-14
FI873363L (fi) 1987-08-03
FI873364A0 (fi) 1987-08-03
ES2038215T3 (es) 1993-07-16
EP0248047B1 (de) 1991-06-19
CA1338627C (en) 1996-10-01
ATE75608T1 (de) 1992-05-15
NO175620B (instruction) 1994-08-01
DE3679908D1 (de) 1991-07-25
FI873364A7 (fi) 1987-08-03
WO1987003480A2 (en) 1987-06-18
FI873363A7 (fi) 1987-08-03
DE3641491A1 (de) 1987-09-17
NO174877B (no) 1994-04-18
JPH0859677A (ja) 1996-03-05
PT83872A (de) 1987-01-01
WO1987003478A2 (en) 1987-06-18
WO1987003478A3 (en) 1987-09-24
DK398587A (da) 1987-07-30
PT83872B (pt) 1989-01-17
DE19375061I2 (de) 2008-11-20
HUT44431A (en) 1988-03-28
JP2857084B2 (ja) 1999-02-10
IE863176L (en) 1987-06-04
DK393187A (da) 1987-07-28
FI873363A0 (fi) 1987-08-03
NO873244D0 (no) 1987-08-03
IE863177L (en) 1987-06-04
HUT44441A (en) 1988-03-28
EP0248047A1 (de) 1987-12-09
IE59778B1 (en) 1994-04-06
EP0230575A2 (de) 1987-08-05
EP0225608A3 (de) 1987-10-28
HU208143B (en) 1993-08-30

Similar Documents

Publication Publication Date Title
NO174877C (no) Fremgangsmåte for fremstilling av et legemiddel med antitumorvirkning
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
PT87820A (pt) Process for the preparation of 1,2,3,5,6-tetrahydro-pyridile anof pyperidile compounds and pharmaceutical compositions therewi
IL67697A (en) 6-substituted-s-triazolo(3,4-a)phthalazine derivatives,their preparation and pharmaceutical compositions containing them
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
NO167570C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive flavonforbindelser.
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
HUT46224A (en) Process for producing pharmaceutical compositions containing prostaglandin e1-derivatives
NO822841L (no) Insekticid middel med virkning mot bladlus.
DE3378120D1 (en) Thiazaspiro derivatives, process for their preparation and pharmaceutical composition
IL134039A0 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them
HUT64548A (en) Method for producing new phosphocipid derivatives and pharmaceutical preparatives containing them
FR2621918B1 (fr) 2',3'-didesoxy-4-thio-uridines, procede de preparation de ces substances et medicaments qui en contiennent
ES516399A0 (es) "procedimiento para la fabricacion de productos farmaceuticos directamente absorbidos por el intestino delgado".
NO170331C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive acyleringsprodukter av bis(2-imidazolin-2-ylhydrazoner)av 9,10-antracen- dikarboksaldehyd
OA08184A (fr) Agents anti-hypertentifs, compositions pharmaceutiques les contenant et procédé de préparation desdits agents et compositions.
DK311284D0 (da) 3-(4'-aminobutylamino)-propylamino-bleomycin-derivater, deres fremstilling og deres anvendelse som laegemidler

Legal Events

Date Code Title Description
MK1K Patent expired